Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In TransMedics To Contact Him Directly To Discuss Their OptionsIf you suffered losses exceeding $50,000 in TransMedics between February 23, 2023 and January 10, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).[You may also click here for additional information]NEW YORK, March 21, 2025 ...

NEW YORK, March 21, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in TransMedics Group, Inc. ("TransMedics" or the "Company") (NASDAQ: TMDX) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of TransMedics investors who were adversely affected by alleged securities fraud between February 28, 2023 and January 10, 2025. Follow the link below to get more information and be contacted by a member of our team:https://zlk.com/pslra-1/transmedics-gr ...

Editor's note: Seeking Alpha is proud to welcome LW Research as a new contributing analyst. You can become one too! Share your best investment idea by submitting your article for review to our editors. Get published, earn money, and unlock exclusive SA Premium access.LW Research is run by a qualified accountant working in the financial services sector mainly in private equity, hedge funds, asset management and venture capital. Since my time working as an accountant I've become extremely well versed at divin ...

NEW YORK, March 20, 2025  /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of TransMedics Group, Inc. (NASDAQ: TMDX).Shareholders who purchased shares of TMDX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/transmedics-group-inc-loss-submission-form-2/?id=137080&from=4 CLASS PERIOD: Fe ...

With the recent market sell-off, now is potentially the time for investors to find their next big winner. After all, if one had invested in stocks during the bear markets of late 2018, the Covid drawdown of 2020, or the interest rate driven drawdown of 2022, you likely would have made out quite well.Coming off a late-year slowdown and short-seller attack, this disruptive medical tech stock is currently over 60% off its all-time highs set just last year. But with recent better-than-expected Q4 results and a ...

NEW YORK, March 18, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against TransMedics Group, Inc. (NASDAQ: TMDX) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in TransMedics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/transmedics-group-inc. Investors have until April 15, 2025, to ask the Court to b ...

NEW YORK, March 18, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in TransMedics Group, Inc. ("TransMedics" or the "Company") (NASDAQ: TMDX) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of TransMedics investors who were adversely affected by alleged securities fraud between February 28, 2023 and January 10, 2025. Follow the link below to get more information and be contacted by a member of our team:https://zlk.com/pslra-1/transmedics-gr ...

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of TransMedics Group, Inc. regarding a class action lawsuit alleging fraudulent practices and misleading statements by the company during the specified class period [1][2]. Group 1: Allegations Against TransMedics - The complaint alleges that TransMedics engaged in kickbacks, fraudulent overbilling, and coercive tactics to generate business and revenue [1]. - It is claimed that the company engaged in unsafe practices, concealed safety issues, and lacked proper safety oversight [1]. - The allegations suggest that these actions exposed TransMedics to increased scrutiny and regulatory risks, leading to materially false and misleading statements about its business and operations [1]. Group 2: Class Action Details - The class period for the lawsuit is defined as February 28, 2023, to January 10, 2025 [1]. - Shareholders are encouraged to register for the class action by April 15, 2025, to potentially become lead plaintiffs [2]. - Participants will be enrolled in a portfolio monitoring system to receive updates on the case's progress [2]. Group 3: Firm's Mission and Commitment - The Gross Law Firm aims to protect investors' rights against deceit, fraud, and illegal business practices [3]. - The firm is dedicated to ensuring companies adhere to responsible business practices and good corporate citizenship [3]. - The firm seeks recovery for investors who suffered losses due to misleading statements or omissions that inflated the company's stock value [3].

Core Viewpoint - A securities class action lawsuit has been filed against TransMedics Group, Inc. for alleged misconduct during the Class Period from February 28, 2023, to January 10, 2025, with a lead plaintiff deadline set for April 15, 2025 [1][2]. Allegations Against TransMedics - The complaint alleges that TransMedics engaged in unethical practices, including the use of kickbacks, fraudulent overbilling, and coercive tactics to generate business and revenue [2]. - It is claimed that the company engaged in unsafe practices, concealed safety issues, and lacked proper safety oversight, which increased regulatory scrutiny and risk [2]. Lead Plaintiff Process - Investors in TransMedics have until April 15, 2025, to seek appointment as a lead plaintiff representative, which involves directing the litigation on behalf of all class members [3]. - The lead plaintiff is typically the investor or small group of investors with the largest financial interest in the case [3]. Firm Background - Kessler Topaz Meltzer & Check, LLP is known for prosecuting class actions and has a reputation for recovering billions for victims of corporate misconduct [4].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against TransMedics Group, Inc. due to allegations of securities law violations, with a deadline for investors to seek lead plaintiff status in a class action lawsuit by April 15, 2025 [2][4]. Group 1: Allegations Against TransMedics - The complaint alleges that TransMedics and its executives made false and misleading statements, failing to disclose practices such as kickbacks, fraudulent overbilling, and coercive tactics to generate revenue [4]. - It is claimed that TransMedics engaged in unsafe practices and concealed safety issues, leading to increased scrutiny and regulatory risks [4]. - The lawsuit asserts that the misleading statements about the company's business and operations resulted in investor damages when the true details became public [4]. Group 2: Market Reaction - Following the release of a report by Scorpion Capital on January 10, 2025, which described TransMedics as a significant healthcare fraud, the company's stock fell by 5.15% on that day [5][6]. - The stock experienced an additional decline of 6.9% on January 13, 2025, indicating a negative market reaction to the allegations [6]. Group 3: Legal Proceedings - Investors who purchased securities in TransMedics between February 23, 2023, and January 10, 2025, are encouraged to discuss their legal rights and options with Faruqi & Faruqi [1][2]. - The role of lead plaintiff in the class action is open to any member of the putative class, with the ability to direct and oversee the litigation [7].